Expression and clinical significance of lncRNA RP11-259P1.1 in small cell lung cancer tissues
10.3872/j.issn.1007-385x.2018.10.011
- VernacularTitle:LncRNARP11-259P1.1在小细胞肺癌组织中的表达及其临床意义
- Author:
LI Xiaohua
1
,
2
;
DAI Bin
3
;
ZHOU Ting
3
;
ZHOU Jing
3
;
XIAO Zhenliang
3
Author Information
1. Department of Respiratory, the Sixth People'
2. s Hospital of Chengdu
3. Department of Respiratory, General Hospital of Chengdu Military Region
- Publication Type:Journal Article
- Keywords:
small cell lung carcinoma (SCLC);
long non-coding RNA;
RP11-259P1.1；chemotherapy drug resistance；prognosis
- From:
Chinese Journal of Cancer Biotherapy
2018;25(10):1042-1047
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the expression of long non-coding RNA RP11-259P1.1 (lncRNA RP11-259P1.1) in small cell lung cancer (SCLC) tissues and to analyze the relationship between lncRNARP11-259P1.1 expression and SCLC clinicopathological characteristics, as well as to investigate its effect in chemoresistance. Methods: Tissue samples, including 158 cases of tumor tissues from SCLC patients, who underwent bronchoscopic biopsy, puncture biopsy and surgical resection, 48 cases of para-cancerous tissues and 40 cases of normal lung tissues, collected from January 2012 to December 2016 in the Sixth People’s Hospital of Chengdu and General Hospital of Chengdu Military Region，were used in this study. The expression of lncRNARP11-259P1.1 was detected by Real-time fluorescence quantitative PCR (qPCR). χ2 test was used to analyze the relationship between the expression of lncRNA RP11-259P1.1 and the clinicopathological characteristics as well as chemotherapeutic resistance in SCLC patients. Relationship between lncRNA RP11259P1.1 expression and prognosis of SCLC patients was analyzed by univariate and multivariate Cox regression analysis. Results: The expression of lncRNA RP11-259P1.1 in SCLC tissues was significantly higher than that in para-cancerous tissues and normal lung tissues (all P < 0.01). The expression of lncRNA RP11-259P1.1 in cancer tissues of chemosensitive group was significantly lower than that of chemoresistant group (P<0.05). The expression of lncRNA RP11-259P 1.1 was not correlated with gender and age, but significantly correlated with tumor stage, metastasis and chemosensitivity (all P<0.05). PFS and OS in patients with high lncRNA RP11-259P 1.1 expression were significantly shorter than those in patients with low expression ([12.25±1.83] vs [22.29±1.58] months, [23.55±1.35] vs [31.75±2.43] months, all P<0.01). The expression of lncRNA RP11-259P 1.1, tumor stage and distant metastasis were the independent prognostic factors in SCLC patients (all P<0.05). Conclusion: The high expression of lncRNA RP11-259P1.1 in SCLC tissues is associated with chemosensitivity and prognosis of SCLC patients, and may be a potential biomarker for prognosis evaluation in SCLC patients.
- Full text:20181011.pdf
